Molecular characterization of suicide by microarray analysis
Several lines of evidence support the idea that individuals who commit suicide have a certain biological predisposition, part of which is given by genes. Studies investigating genetic factors increasing suicide predisposition have been limited by current knowledge of the suicide neurobiology and hav...
Saved in:
Published in | American journal of medical genetics. Part C, Seminars in medical genetics Vol. 133C; no. 1; pp. 48 - 56 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken
Wiley Subscription Services, Inc., A Wiley Company
15.02.2005
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Several lines of evidence support the idea that individuals who commit suicide have a certain biological predisposition, part of which is given by genes. Studies investigating genetic factors increasing suicide predisposition have been limited by current knowledge of the suicide neurobiology and have typically investigated one or a few genes at a time, whereas it is anticipated that several genes account for the total genetic variance mediating suicide. This review focuses on the advantages and the interest of using the microarray technology to investigate the neurobiology of suicide and discusses, by means of a data analysis example, the possible methodological problems and bioinformatic strategies that should be employed in order to separate the signal from the large amount of background noise, which is usually generated in such studies. Microarray expression studies and related platforms are promising tools to gain better insight into the neurobiology of suicide. © 2005 Wiley‐Liss, Inc. |
---|---|
Bibliography: | ark:/67375/WNG-80Z3J4HP-8 istex:C6F17575039E69C7175F15A23D4F07C200EE7D6A ArticleID:AJMG30046 P. Adolfo Sequeira, M.Sc. is a molecular biologist who is currently completing his Ph.D. training in the genetics of mood disorders and suicide at the McGill Group for Suicide Studies, McGill University. Jarlath M.H. ffrench‐Mullen is a neuroscientist and currently scientific director of the Central Nervous System (CNS) program at GeneLogic, Inc. Gustavo Turecki M.D., Ph.D. is a psychiatrist and CIHR scholar who directs the McGill Group for Suicide Studies at McGill University. Fuad G. Gwadry is a mathematician who has been working on bioinformatics and chemoinformatic solutions for the drug discovery process. Currently he is CSO with G‐BioChem Solutions, a scientific research firm. Glenn Hoke is past Vice President of Research & Development at Gene Logic, Inc., and currently he is President and CSO at Dyad Pharmaceutical Corp. ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
ISSN: | 1552-4868 1552-4876 |
DOI: | 10.1002/ajmg.c.30046 |